A detailed history of Eaton Vance Management transactions in Pulmonx Corp stock. As of the latest transaction made, Eaton Vance Management holds 23,062 shares of LUNG stock, worth $146,213. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,062
Previous 23,062 -0.0%
Holding current value
$146,213
Previous $339,000 13.27%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$29.72 - $45.1 $5.53 Million - $8.4 Million
-186,189 Reduced 88.98%
23,062 $740,000
Q3 2021

Nov 15, 2021

BUY
$35.98 - $44.48 $3.28 Million - $4.05 Million
91,127 Added 77.15%
209,251 $7.53 Million
Q2 2021

Aug 16, 2021

BUY
$37.61 - $48.0 $1.88 Million - $2.4 Million
49,983 Added 73.35%
118,124 $5.21 Million
Q1 2021

May 17, 2021

SELL
$44.0 - $67.54 $1.4 Million - $2.15 Million
-31,859 Reduced 31.86%
68,141 $3.12 Million
Q4 2020

Feb 12, 2021

BUY
$39.31 - $69.02 $3.93 Million - $6.9 Million
100,000 New
100,000 $6.9 Million

Others Institutions Holding LUNG

About Pulmonx Corp


  • Ticker LUNG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,268,400
  • Market Cap $236M
  • Description
  • Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...
More about LUNG
Track This Portfolio

Track Eaton Vance Management Portfolio

Follow Eaton Vance Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

News

Stay updated on Eaton Vance Management with notifications on news.